The board of directors of Abbott today declared a quarterly common dividend of 51 cents per share.
The global smart insulin pens market will grow from $0.09 billion in 2022 to $0.10 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The market is expected to grow to $0.12 billion in 2027 at a CAGR of 6.2%.
#insulin pen
According to Arizton's latest research report, the insulin pump market will grow at a CAGR OF 8.4% during 2022-2028. New products launched and technological advancement in diabetes care, increasing demand for closed-loop technology, and transition of patients from multiple daily injections to the insulin pump are key trends in the market.
#insulin pump
#closed loop
Nemaura Medical, Inc announces that CEO Dr. Faz Chowdhury will participate in a fireside chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference that is being held virtually on February 21 – 24, 2023.
Lark Health, a leading digital care company for the prevention and management of chronic conditions, and Smart Meter, the leading supplier of Remote Patient Monitoring (“RPM”) solutions to a nationwide network of SmartPartners™, today announced a collaboration targeting the care and management of patients with type 2 diabetes across health systems. Lark’s clinically proven Diabetes management program, Diabetes Care, combined with the proprietary cellular-enabled iGlucose® glucose meter from Smart Meter, will improve health systems' ability to manage patients with Type 2 Diabetes.
#product & service
#coaching
#rpm
Netherlands Diabetes Market will reach US$ 3.36 Billion in 2028 according to the publisher. The Netherlands Market is segmented into Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring Devices, Insulin Pumps, and Insulin Pens. The prevalence of diabetes is increasing among all ages in the Netherlands, primarily due to increase in overweight and obesity, unhealthy diet, and physical inactivity.
#insulin pump
#insulin pen
#cgm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on Thursday, March 2, 2023 at 2:45pm ET (11:45am PT) ; Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023 at 12:50pm ET (9:50am PT) ; Raymond James & Associates’ 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023 at 9:50am ET (6:50am PT) ; Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023 at 8:40am ET (5:40am PT), and Barclays Global Healthcare Conference on Tuesday, March 14, 2023 at 11:15am ET (8:15am PT).
The global insulin pens, syringes, pumps and injectors market will grow from $21.09 billion in 2022 to $22.81 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%.The insulin pens, syringes, pumps and injectors market is expected to grow to $29.75 billion in 2027 at a CAGR of 6.9%.
#insulin pen
#insulin pump
Insulet Corporation today announced it has acquired the assets of Automated Glucose Control LLC (AGC), a company in Palo Alto, California focused on developing and commercializing best in class automated insulin delivery technology. AGC and Insulet entered into a license agreement and partnership in 2016 based on patents and other intellectual property that AGC had licensed from the Dr. Francis J. Doyle III laboratory at the University of California, Santa Barbara. The two co-founders of AGC, Dr. Jennifer Schneider and Dr. Thomas Peyser, consulted with Insulet with respect to the licensed technology as part of Insulet’s development of its Omnipod® 5 Automated Insulin Delivery system. Insulet paid $25M for the acquisition of AGC’s assets, which include the license from the University of California and other intellectual property.
#product & service
#insulin pump
#closed loop
Insulet Corporation today announced that management will present at two upcoming investor conferences: The Raymond James & Associates 44th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 7, 2023 at 9:15 a.m. (Eastern Time), and The Cowen 43rd Annual Health Care Conference in Boston, MA on Wednesday, March 8, 2023 at 10:30 a.m. (Eastern Time).